323 Selective fetoscopic laser or expectant management for quintero stage i twin-twin transfusion: a cost-effectiveness analysis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2020.12.344 ◽

2021 ◽

Vol 224 (2) ◽

pp. S212-S213

Author(s):

Jordan Stone ◽

Aimen Shaaban ◽

William A. Grobman ◽

Ashish Premkumar

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Cost Effectiveness Analysis ◽

Stage I ◽

Effectiveness Analysis

Download Full-text

Induction of labour at 41 weeks of gestation versus expectant management and induction of labour at 42 weeks of gestation: a cost‐effectiveness analysis

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/1471-0528.16929 ◽

2021 ◽

Author(s):

Mårten Alkmark ◽

Ulla‐Britt Wennerholm ◽

Sissel Saltvedt ◽

Christina Bergh ◽

Ylva Carlsson ◽

...

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Cost Effectiveness Analysis ◽

Induction Of Labour ◽

Effectiveness Analysis

Download Full-text

Expectant Management vs. Prompt Delivery for Severe Preeclampsia Diagnosed 30-33 weeks: A Week-by-Week Cost-Effectiveness Analysis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2021.11.301 ◽

2022 ◽

Vol 226 (1) ◽

pp. S172

Author(s):

Olivia Curl ◽

Claire H. Packer ◽

Sarina R. Chaiken ◽

Uma Doshi ◽

Aaron B. Caughey

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Cost Effectiveness Analysis ◽

Severe Preeclampsia ◽

Effectiveness Analysis

Download Full-text

20: Induction of labor versus expectant management at 39 weeks: a cost-effectiveness analysis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2018.11.023 ◽

2019 ◽

Vol 220 (1) ◽

pp. S18

Author(s):

Alyssa R. Hersh ◽

Ashley E. Skeith ◽

James A. Sargent ◽

Aaron B. Caughey

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Cost Effectiveness Analysis ◽

Induction Of Labor ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of non-risk-adapted active surveillance for post-orchiectomy management of clinical stage I seminomas

European Urology Open Science ◽

10.1016/s2666-1683(20)34106-9 ◽

2020 ◽

Vol 19 ◽

pp. e2223

Author(s):

M.M. Huang ◽

Z.T. Su ◽

J.G. Cheaib ◽

M.J. Biles ◽

M.E. Allaf ◽

...

Keyword(s):

Cost Effectiveness ◽

Active Surveillance ◽

Clinical Stage ◽

Cost Effectiveness Analysis ◽

Stage I ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness Analysis of Non–risk-adapted Active Surveillance for Postorchiectomy Management of Clinical Stage I Seminoma

European Urology Focus ◽

10.1016/j.euf.2020.06.012 ◽

2020 ◽

Author(s):

Mitchell M. Huang ◽

Zhuo T. Su ◽

Joseph G. Cheaib ◽

Michael J. Biles ◽

Mohamad E. Allaf ◽

...

Keyword(s):

Cost Effectiveness ◽

Active Surveillance ◽

Clinical Stage ◽

Cost Effectiveness Analysis ◽

Stage I ◽

Effectiveness Analysis ◽

Stage I Seminoma

Download Full-text

Expectant management of preterm premature rupture of membranes at 34 weeks: a cost effectiveness analysis

The Journal of Maternal-Fetal & Neonatal Medicine ◽

10.1080/14767058.2021.2017874 ◽

2021 ◽

pp. 1-9

Author(s):

Jacqueline M. Powell ◽

Zoë C. Frank ◽

Grace V. Clark ◽

Jamie O. Lo ◽

Aaron B. Caughey

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Cost Effectiveness Analysis ◽

Premature Rupture Of Membranes ◽

Premature Rupture ◽

Preterm Premature Rupture ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Treatment Strategies for Stage I and II Endometrial Cancer

Journal of Obstetrics and Gynaecology Canada ◽

10.1016/s1701-2163(16)32387-8 ◽

2007 ◽

Vol 29 (2) ◽

pp. 131-139 ◽

Author(s):

Janice S. Kwon ◽

Mark S. Carey ◽

Sue J. Goldie ◽

Jane J. Kim

Keyword(s):

Endometrial Cancer ◽

Cost Effectiveness ◽

Treatment Strategies ◽

Cost Effectiveness Analysis ◽

Stage I ◽

Effectiveness Analysis

Download Full-text

MP11-20 COST-EFFECTIVENESS ANALYSIS OF NON-RISK-ADAPTED ACTIVE SURVEILLANCE FOR POST-ORCHIECTOMY MANAGEMENT OF CLINICAL STAGE I SEMINOMAS

The Journal of Urology ◽

10.1097/ju.0000000000000831.020 ◽

2020 ◽

Vol 203 ◽

pp. e143

Author(s):

Mitchell M. Huang* ◽

Zhuo T. Su ◽

Joseph G. Cheaib ◽

Michael J. Biles ◽

Mohamad E. Allaf ◽

...

Keyword(s):

Cost Effectiveness ◽

Active Surveillance ◽

Clinical Stage ◽

Cost Effectiveness Analysis ◽

Stage I ◽

Effectiveness Analysis

Download Full-text

Linear Accelerator or Robotic SBRT for Peripheral Inoperable Stage I Non–small Cell Lung Cancer: A Cost-Effectiveness Analysis

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1548 ◽

2017 ◽

Vol 99 (2) ◽

pp. E395-E396

Author(s):

M.D. Frelinghuysen ◽

J.P. Pignol ◽

J. Nuyttens

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Linear Accelerator ◽

Cost Effectiveness Analysis ◽

Stage I ◽

Small Cell Lung ◽

Effectiveness Analysis

Download Full-text

Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2019.02.017 ◽

2019 ◽

Vol 220 (6) ◽

pp. 590.e1-590.e10 ◽

Author(s):

Alyssa R. Hersh ◽

Ashley E. Skeith ◽

James A. Sargent ◽

Aaron B. Caughey

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Cost Effectiveness Analysis ◽

Induction Of Labor ◽

Low Risk ◽

Effectiveness Analysis ◽

Nulliparous Women

Download Full-text